Synthetic versions of the hormone somatostatin that acts on the pituitary gland, controlling the release of growth hormone.
These drugs are used to treat acromegaly and symptoms associated with some other hormone-secreting tumours (particularly in carcinoid syndrome).
Octreotide is a common somatostatin analogue.
Also known as the growth-hormone-releaseinhibiting factor, this is a hormone secreted by the HYPOTHALAMUS and some non-nervous tissues (including the gastrointestinal tract and pancreas). It stops the pituitary-releasing somatotrophin – GROWTH HORMONE. Somatostatin and growth-hormone-releasing hormone are controlled by complicated neural mechanisms linked to exercise, sleep patterns, stress, NEUROTRANSMITTERS and blood GLUCOSE.... somatostatin
a group of synthetic human insulins with specific alterations in their amino-acid sequences designed to modify their rate of absorption from the subcutaneous injection site. Some are absorbed more rapidly and have a shorter duration of action than conventional short-acting human insulin; others are absorbed more slowly at a more consistent rate than conventional medium-acting *isophane insulin to give a more sustained control of fasting and premeal blood glucose levels and therefore a reduced risk of *hypoglycaemia. These analogues include the short-acting insulin aspart, insulin glulisine, and insulin lispro; the long-acting insulin detemir and insulin glargine; and the ultra-long-acting insulin degludec.... insulin analogues
Health Encyclopedia